/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Amicus Therapeutics

Amicus Therapeutics

USA

Amicus is a wholly owned subsidiary of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions.

Healthcare & Biotech

Amicus Therapeutics, based in USA, has 2 investors on file, among them Canaan and NEA. Its site was last checked 7 Nov 2026: site answers.

amicustherapeutics.ca

Investors

2 investors on file
InvestorEvidenceType
CanaanPortfolio pageVenture capital
NEAPortfolio pageVenture capital

More from Canaan

201 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (21%), AI & Machine Learning (17%), Fintech (12%).

Acesion PharmaAcesion Pharma aims to develop more efficacious and safe drugs for the…Actio BiosciencesActio Biosciences is involved in clinical trials for therapies, includ…Aer TherapeuticsAer Therapeutics develops a therapy to liquify mucus plugs in the lung…Arbor AIArbor connects clients with verified industry experts and consumers fo…ArrakisArrakis Therapeutics creates genetic medicines, specifically RNA-targe…

See Canaan's full profile · Who invests alongside it

More from NEA

528 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (22%), AI & Machine Learning (19%), Fintech (10%).

858 Therapeutics858 Therapeutics is a clinical-stage biotechnology company developing …AVEO OncologyAVEO is an oncology-focused biopharmaceutical company committed to del…AbcuroAbcuro develops therapies for autoimmune diseases and cancer.Acadia PharmaceuticalsAcadia Pharmaceuticals advances treatment in neurological disorders an…AcquiaAcquia provides a digital experience platform for managing content, co…

See NEA's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Amicus Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Canaan adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/amicustherapeutics.ca/investors

# also
GET /v1/companies/amicustherapeutics.ca
GET /v1/companies/amicustherapeutics.ca/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing